CENTRAL NERVOUS SYSTEM
Helping you to take back control
The central nervous system includes your brain and spinal cord. It manages everything your body does – thought, movement, emotion, heart rate, hormones, and much more.1,2
It i’s no surprise then that diseases of the central nervous system can have a huge impact on peoples’ lives. Conditions such as epilepsy, vertigo and depression can turn your life upside down and stop you from doing what you love.3-5

Conditions we help treat
Medicines in this therapeutic area are indicated for conditions such as:
- Epilepsy: A relatively common neurological disorder, characterized by recurrent seizures— a surge of uncontrolled electrical activity in the brain leading to involuntary muscle movements, twitching or stiffness, loss of consciousness, or other unusual sensations. In most instances, epileptic seizures can be managed with anti-seizure medicines, dietary adjustments and lifestyle adaptations. 6
- Vertigo: Vertigo is the feeling that the world around you is spinning while you are standing still.7 It is often caused by an inner ear problem.8 The inner ear – or vestibular system – sends signals to the brain to regulate movement and balance.7 The impact of vertigo on life can be significant enough to disrupt daily activities.9 But vertigo can be treated to help you move forward with confidence.10
- Depression: Depression prevents millions of people all over the world from leading their best lives.5 Symptoms of depression include irritability, loss of interest or pleasure in most or all normal activities, lack of energy, feelings of sadness and suicidal ideation.11 Incredibly, 80% of the burden of depression occurs in emerging countries.12 Medication may help to ease the symptoms and help people to get back to their normal daily routines.5
Our CNS medicines include:
- Betaserc® , Serc (Betahistine dihydrochloride)
- Depakote® (Divalproex sodium)
- Epival® (Valproate sodium)
- Luvox®, Faverin® (fluvoxamine)
- Serc® (Betahistine Dihydrochloride)
This page contains information about prescription-only medicines. These products may not be available in all countries, and prescribing indications may vary by region. The content is intended for informational purposes only and should not be interpreted as medical advice or an encouragement to use these medicines without a doctor’s prescription. For specific guidance, please consult your local Abbott representative or healthcare provider.
Betaserc® (betahistine)
Packaging may vary by country. Please refer to your local product label.
Read More
Depakene® (valproid acid)
Brand names may vary by country. This information refers to the product as marketed in selected countries.
Read More
Depakote (divalproex sodium)
Packaging may vary by country. Please refer to your local product label.
Read More
Luvox-fluvoxamine-maleate
Packaging may vary by country. Please refer to your local product label.
Read MoreREFERENCES
- Cleveland Clinic. Central Nervous System: What Does It Do? Last reviewed November 12, 2023. Accessed July 9, 2024. https://my.clevelandclinic.org/health/body/central-nervous-system-cns
- Gordan R, Gwathmey JK, Xie LH. Autonomic and endocrine control of cardiovascular function. World J Cardiol. 2015;7(4):204-214. doi:10.4330/wjc.v7.i4.204
- Josephson CB, Jetté N. Psychiatric comorbidities in epilepsy. Int Rev Psychiatry. 2017;29(5):409-424. doi:10.1080/09540261.2017.1302412
- Bösner S, Schwarm S, Grevenrath P, et al. Prevalence, aetiologies and prognosis of the symptom dizziness in primary care – a systematic review. BMC Fam Pract. 2018;19(1):33. doi:10.1186/s12875-017-0695-0
- Kessler RC. The costs of depression. Psychiatr Clin North Am. 2012;35(1):1-14. doi:10.1016/j.psc.2011.11.005
- Cleveland Clinic. Epilepsy: What It Is, Causes, Symptoms, Diagnosis & Treatment. Last reviewed March 11, 2022. Accessed July 9, 2024. https://my.clevelandclinic.org/health/diseases/17636-epilepsy
- Benecke H, Agus S, Kuessner D, Goodall G, Strupp M. The Burden and Impact of Vertigo: Findings from the REVERT Patient Registry. Front Neurol. 2013;4:136. Published 2013 Oct 2. doi:10.3389/fneur.2013.00136
- National Health Service (NHS). Vertigo. Last reviewed May 2, 2023. Accessed July 9, 2024. https://www.nhs.uk/conditions/vertigo
- Agrawal Y, Ward BK, Minor LB. Vestibular dysfunction: prevalence, impact and need for targeted treatment. J Vestib Res. 2013;23(3):113-117. doi:10.3233/VES-130498
- Strupp M, Brandt T. Diagnosis and treatment of vertigo and dizziness. Dtsch Arztebl Int. 2008;105(10):173-180. doi:10.3238/arztebl.2008.0173
- Mayo Clinic. Depression (major depressive disorder). Last reviewed October 14, 2022. Accessed July 9, 2024. https://www.mayoclinic.org/diseases-conditions/depression/symptoms-causes/syc-20356007
- Kim J, Aryee LMD, Bang H, et al. Effectiveness of Digital Mental Health Tools to Reduce Depressive and Anxiety Symptoms in Low- and Middle-Income Countries: Systematic Review and Meta-analysis. JMIR Ment Health. 2023;10:e43066. doi:10.2196/43066.